Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction

被引:270
作者
Kurts, C
Miller, JFAP
Subramaniam, RM
Carbone, FR
Heath, WR [1 ]
机构
[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia
[2] Monash Univ Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia
关键词
CD8(+) T lymphocytes; T cell activation; antigen presentation; antigen presenting cells; apoptosis;
D O I
10.1084/jem.188.2.409
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naive T cells recirculate mainly within the secondary lymphoid compartment, but once activated they can enter peripheral tissues and perform effector functions. To activate naive T cells, foreign antigens must traffic from the site of infection to the draining lymph nodes, where they can be presented by professional antigen presenting cells. For major histocompatibility complex class I-restricted presentation to CD8(+) T cells, this can occur via the cross-presentation pathway. Here, we investigated the conditions allowing antigen access to this pathway. We show that the level of antigen expressed by peripheral tissues must be relatively high to facilitate cross-presentation to naive CD8(+) T cells. Below this level, peripheral antigens did not stimulate by cross-presentation and were ignored by naive CD8(+) T cells, although they could sensitize tissue cells for destruction by activated cytotoxic T lymphocytes (CTLs). Interestingly, CTL-mediated tissue destruction facilitated cross-presentation of low dose antigens for activation of naive CD8(+) T cells. This represents the first in vivo evidence that cellular destruction can enhance access of exogenous antigens to the cross-presentation pathway. These data indicate that the cross-presentation pathway focuses on high dose antigens and those released during tissue destruction.
引用
收藏
页码:409 / 414
页数:6
相关论文
共 26 条
[1]   NONTOLERANCE AND AUTOANTIBODIES TO A TRANSGENIC SELF ANTIGEN EXPRESSED IN PANCREATIC BETA-CELLS [J].
ADAMS, TE ;
ALPERT, S ;
HANAHAN, D .
NATURE, 1987, 325 (6101) :223-228
[2]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[3]   CROSS-PRIMING OF MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELLS UPON IMMUNIZATION WITH THE HEAT-SHOCK PROTEIN GP96 [J].
ARNOLD, D ;
FAATH, S ;
RAMMENSEE, HG ;
SCHILD, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :885-889
[4]   Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Miller, JFAP ;
Heath, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :65-70
[5]   CLASS DISCRIMINATION IN THE WORLD OF IMMUNOLOGY [J].
BEVAN, MJ .
NATURE, 1987, 325 (6101) :192-194
[6]  
BEVAN MJ, 1976, J IMMUNOL, V117, P2233
[7]   CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1283-1288
[8]   Induction of autoimmune diabetes by oral administration of autoantigen [J].
Blanas, E ;
Carbone, FR ;
Allison, J ;
Miller, JFAP ;
Heath, WR .
SCIENCE, 1996, 274 (5293) :1707-1709
[9]   CLASS-I-RESTRICTED PROCESSING AND PRESENTATION OF EXOGENOUS CELL-ASSOCIATED ANTIGEN INVIVO [J].
CARBONE, FR ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) :377-387
[10]  
GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.iy.11.040193.002155